Satish Sharma, PhD
About Satish Sharma, PhD
Satish Sharma, PhD, is a Principal Scientist at Bristol Myers Squibb in Devens, MA, with over 20 years of experience in medical microbiology and bacteriology. He has held multiple roles at Bristol Myers Squibb since joining in 2016 and has a strong background in both academic and industrial research environments.
Title
Satish Sharma, PhD, is currently a Principal Scientist at Bristol Myers Squibb in Devens, MA.
Professional Experience at Bristol Myers Squibb
Satish Sharma joined Bristol Myers Squibb in 2016 as Scientist II in the Greater Boston Area, MA. He progressed to Senior Scientist in Devens, MA, where he worked from 2018 to 2020. He is currently serving as Principal Scientist at the same location, where he has been responsible for developing analytical methods for detecting impurities in late-stage biologics.
Previous Positions
Before joining Bristol Myers Squibb, Satish Sharma held various research positions. He worked as a Scientist at Janssen Pharmaceuticals, Inc of Johnson & Johnson (c/o Eurofins Lancaster Labs. PSS) in Malvern, PA. He also served as Principal Scientist at Sonitu Pharmaceuticals in Doylestown, PA. Additionally, he was a Senior Research Scientist at the University of Pennsylvania and held postdoctoral fellow positions at Thomas Jefferson University and the University of Pennsylvania.
Education and Expertise
Satish Sharma earned a Doctor of Philosophy (PhD) in Medical Microbiology and Bacteriology from JMI and VP Chest Institute Delhi, University of Delhi, India. He also holds a Master of Science (M.Sc.) degree in Medical Microbiology from the Postgraduate Institute of Medical Education and Research. His extensive knowledge in medical microbiology and bacteriology is backed by over 20 years of experience.
Development of Analytical Methods
At Bristol Myers Squibb, Satish Sharma has led a team focused on developing analytical methods for detecting impurities in late-stage biologics. His work has contributed to process analytics and ensuring the timely delivery of results. Sharma's extensive experience encompasses working with CHO and microbial-based large molecule therapeutics, reflecting his capability in both academic and industrial research environments.